Almirall, S.A. (ALMRY)
OTCMKTS · Delayed Price · Currency is USD
10.56
+0.88 (9.08%)
At close: Apr 24, 2025
Accolade Market Cap
Almirall has a market cap or net worth of $2.54 billion as of August 1, 2025. Its market cap has increased by 14.28% in one year.
Market Cap
2.54B
Enterprise Value
2.61B
Revenue
1.24B
Ranking
n/a
PE Ratio
101.35
Stock Price
$10.56
Market Cap Chart
Since June 20, 2007, Almirall's market cap has decreased from 3.19B to 2.54B, a decrease of -20.27%. That is a compound annual growth rate of -1.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.54B | 39.53% |
| Dec 31, 2024 | 1.82B | -6.67% |
| Dec 29, 2023 | 1.95B | 11.19% |
| Dec 30, 2022 | 1.75B | -23.76% |
| Dec 30, 2021 | 2.30B | -3.32% |
| Dec 31, 2020 | 2.38B | -17.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |